Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions — Stella
Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations(13 sites)
Spain
Hospital Universitario San Juan Alicante, Alicante
Hospital Universitari Germans Trias I Pujol, Badalona
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario Virgen de La Arrixaca, El Palmar
Hospital Universitario La Paz, Fuencarral-El Pardo
Hospital Universitario Juan Ramón Jiménez, Huelva
Hospital Universitario de Leon, León
Hospital Universitari Arnau de Vilanova, Lleida
Hospital Universitario Lucus Agustí, Lugo
Hospital Regional Universitario de Málaga, Málaga
Hospital Universitario de Canarias, San Cristóbal de La Laguna
Hospital Clínico Universitario de Santiago, Santiago de Compostela